ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 170 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $418,524 | -53.5% | 179,624 | -10.8% | 0.00% | – |
| Q1 2024 | $900,571 | -85.4% | 201,470 | -89.5% | 0.00% | -100.0% |
| Q4 2023 | $6,160,035 | +1462.1% | 1,919,014 | +1442.6% | 0.00% | – |
| Q3 2023 | $394,342 | -62.2% | 124,398 | -40.7% | 0.00% | -100.0% |
| Q2 2023 | $1,042,537 | +20940.1% | 209,766 | -79.1% | 0.00% | -66.7% |
| Q1 2023 | $4,955 | -75.9% | 1,002,996 | -69.4% | 0.00% | -72.7% |
| Q4 2022 | $20,601 | -99.9% | 3,275,124 | +134.5% | 0.01% | +22.2% |
| Q3 2022 | $15,082,000 | +70.3% | 1,396,479 | +79.8% | 0.01% | +80.0% |
| Q2 2022 | $8,856,000 | +70.2% | 776,872 | +36.0% | 0.01% | +66.7% |
| Q1 2022 | $5,204,000 | +125.0% | 571,206 | +268.4% | 0.00% | +200.0% |
| Q4 2021 | $2,313,000 | -60.6% | 155,033 | -32.2% | 0.00% | -75.0% |
| Q3 2021 | $5,876,000 | -55.4% | 228,623 | -54.8% | 0.00% | -50.0% |
| Q2 2021 | $13,178,000 | +31.9% | 505,295 | +78.6% | 0.01% | +14.3% |
| Q1 2021 | $9,989,000 | -23.2% | 282,965 | -45.1% | 0.01% | -30.0% |
| Q4 2020 | $13,011,000 | +405.5% | 515,482 | +655.3% | 0.01% | +233.3% |
| Q3 2020 | $2,574,000 | -71.0% | 68,248 | -67.1% | 0.00% | -75.0% |
| Q2 2020 | $8,871,000 | +786.2% | 207,179 | +302.3% | 0.01% | +500.0% |
| Q1 2020 | $1,001,000 | -46.4% | 51,501 | -28.4% | 0.00% | 0.0% |
| Q4 2019 | $1,868,000 | -31.4% | 71,893 | -28.1% | 0.00% | -50.0% |
| Q3 2019 | $2,725,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $4,189,720 | 4.58% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 689,912 | $1,607,495 | 2.03% |
| Lynx1 Capital Management LP | 2,228,295 | $5,191,927 | 1.87% |
| Wildcat Capital Management, LLC | 2,920,787 | $6,805,434 | 1.66% |
| TPG GP A, LLC | 18,716,306 | $43,608,993 | 1.00% |
| Boxer Capital, LLC | 3,850,000 | $8,970,500 | 0.47% |
| Vestal Point Capital, LP | 2,200,000 | $5,126,000 | 0.38% |
| DAFNA Capital Management LLC | 605,100 | $1,409,883 | 0.34% |
| Frazier Life Sciences Management, L.P. | 2,867,750 | $6,681,858 | 0.31% |
| Coastal Bridge Advisors, LLC | 406,847 | $947,954 | 0.24% |